Royce & Associates LP reduced its stake in Utah Medical Products, Inc. (NASDAQ:UTMD) by 5.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,087 shares of the medical instruments supplier’s stock after selling 2,113 shares during the period. Royce & Associates LP owned 0.92% of Utah Medical Products worth $2,507,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. Acrospire Investment Management LLC grew its stake in Utah Medical Products by 339.1% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,919 shares of the medical instruments supplier’s stock worth $139,000 after acquiring an additional 1,482 shares in the last quarter. Strs Ohio grew its stake in Utah Medical Products by 8.0% in the 2nd quarter. Strs Ohio now owns 2,700 shares of the medical instruments supplier’s stock worth $195,000 after acquiring an additional 200 shares in the last quarter. Prudential Financial Inc. bought a new position in Utah Medical Products in the 2nd quarter worth about $233,000. The Manufacturers Life Insurance Company grew its stake in Utah Medical Products by 15.4% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,355 shares of the medical instruments supplier’s stock worth $242,000 after acquiring an additional 448 shares in the last quarter. Finally, OxFORD Asset Management LLP bought a new position in Utah Medical Products in the 2nd quarter worth about $267,000. Institutional investors and hedge funds own 66.67% of the company’s stock.
Utah Medical Products, Inc. (NASDAQ:UTMD) traded up $1.70 during midday trading on Friday, hitting $83.00. 9,997 shares of the stock were exchanged, compared to its average volume of 9,975. Utah Medical Products, Inc. has a 1 year low of $58.50 and a 1 year high of $85.00. The company has a market capitalization of $308.68, a P/E ratio of 22.55 and a beta of 0.78.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, January 3rd. Stockholders of record on Friday, December 15th were paid a dividend of $0.27 per share. The ex-dividend date was Thursday, December 14th. This is an increase from Utah Medical Products’s previous quarterly dividend of $0.27. This represents a $1.08 dividend on an annualized basis and a dividend yield of 1.30%. Utah Medical Products’s dividend payout ratio (DPR) is currently 29.35%.
Separately, BidaskClub upgraded shares of Utah Medical Products from a “hold” rating to a “buy” rating in a research note on Wednesday, December 6th.
COPYRIGHT VIOLATION WARNING: “Royce & Associates LP Sells 2,113 Shares of Utah Medical Products, Inc. (NASDAQ:UTMD)” was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece of content on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this piece of content can be viewed at https://ledgergazette.com/2018/01/13/royce-associates-lp-sells-2113-shares-of-utah-medical-products-inc-utmd.html.
About Utah Medical Products
Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.